Label Changes for:

Sumavel DosePro (sumatriptan) injection for subcutaneous use

June 2011

Changes have been made to the CONTRAINDICATIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2011 

Summary View  

 

 

CONTRAINDICATIONS

Do not use within 24 hours of treatment with Ergotamine-Containing or Ergot-Type Medications or Other 5-HT1 Agonists (e.g. triptans)
  • ...(with the exception of a single dose of another sumatriptan product, provided the doses are separated by at least 1 hour)
Hide
(web1)